Single-cell RNA sequencing decodes celltype- specific pathogenesis in Alzheimer’s disease
DOI:
https://doi.org/10.61173/vcqdw178Keywords:
Alzheimer’s disease, single-cell RNA sequencing, cell-type-specific pathogenesis, disease-associated microgliaAbstract
Alzheimer ’s disease (AD) is the most prevalent neurodegenerative dementia, characterized by progressive cognitive decline, amyloid-beta (Aβ) plaques, and neurofibrillary tangles. Its cell-type-specific pathogenic mechanisms remain unclear due to conventional bulk sequencing’s limitation of averaging gene expression across heterogeneous brain tissues, hindering curative therapy development. Single-cell RNA sequencing (scRNA-seq) has emerged as a transformative tool to dissect AD’s cellular heterogeneity, enabling highresolution analysis of cell-type-specific transcriptional changes. This paper synthesizes key scRNA-seq findings in AD: it reveals region-dependent vulnerability of excitatory and inhibitory neurons, leading to disrupted excitatoryinhibitory (E/I) balance, identifies dynamic transitions of disease-associated microglia (DAM) from protective phagocytosis to maladaptive neuroinflammation, and uncovers disease-associated astrocytes (DAA) contributing to pathology via excitotoxicity, inflammation, and lipid dysregulation. It also discusses scRNA-seq limitations (e.g., postmortem sample reliance, high costs) and proposes future directions like spatial transcriptomics integration. By summarizing scRNA-seq-driven insights, this paper provides a foundation for cell-type-specific therapeutic strategies and precision medicine in AD.
References
[1] Mathys, H., Yang, Z., Wang, M., Gao, F., Qian, X., Zhang, B., & Menon, V. (2024). Single-cell multiregion dissection of Alzheimer’s disease reveals region‐dependent transcriptomic signatures. Nature, 627(8001), 556–563.
[2] Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, Dean&Francis ISSN 2959-409X O., Dvir-Szternfeld, R., Ulland, T. K., ... & Amit, I. (2017). A unique microglia type associated with restricting development of Alzheimer’s disease. Cell, 169(7), 1276-1290.e17.
[3] Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., ... & Barres, B. A. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 541(7638), 481-487.
[4] Tasic, B., Yao, Z., Graybuck, L. T., Smith, K. A., Nguyen, T. N., Bertagnolli, D., ... & Zeng, H. (2018). Shared and distinct transcriptomic cell types across neocortical areas. Nature, 563(7729), 72-78.
[5] Mathys, H., Peng, Z., Boix, C. A., Leary, N., Babu, S., Abdurrob, F., ... & Tsai, L. H. (2024). Single-cell atlas of the entire human brain reveals neuronal vulnerability in Alzheimer’s disease. Nature.
[6] Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., Martorell, A. J., Ransohoff, R. M., Hafler, B. P., Bennett, D. A., Kellis, M., & Tsai, L.-H. (2019). Singlecell transcriptomic analysis of Alzheimer’s disease. Nature, 570(7761), 332–337.
[7] Zhou, Y., Song, W. M., Andhey, P. S., Swain, A., Levy, T., Miller, K. R., Poliani, P. L., Cominelli, M., Grover, S., Gilfillan, S., Cella, M., Ulland, T. K., Zaitsev, K., Miyashita, A., Ikeuchi, T., Harari, O., Benitez, B. A., Cruchaga, C., ... Colonna, M. (2020). Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease. Cell Reports, 31(13), 107843.
[8] Palop, J. J., & Mucke, L. (2010). Amyloid-β–induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nature Neuroscience, 13(7), 812–818.
[9] Mathys, H., Peng, Z., Boix, C. A., Leary, N., Babu, S., Abdurrob, F., Jiang, X., Ng, A. P., Ghafari, K., Kunisky, A. K., Whitesell, J. D., Yao, M., Sahan, M., Ratan, A., Galani, K., Liu, L., Ruan, Z., Liu, H., Liu, Y., … Tsai, L.-H. (2024). Single-cell atlas of the entire human brain reveals neuronal vulnerability in Alzheimer’s disease. Nature, 631(8022), 874–883.
[10] Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch- Natan, O., Dvir-Szternfeld, R., Ulland, T. K., ... & Amit, I. (2017). A unique microglia type associated with restricting development of Alzheimer’s disease. Cell, 169(7), 1276-1290.e17.
[11] Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., Greco, D. J., Smith, S. T., Tweet, G., Humulock, Z., Zrzavy, T., Conde-Sanroman, P., Gacias, M., Weng, Z., Chen, H., … Butovsky, O. (2017). The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity, 47(3), 566–581.e9.
[12] Habib, N., McCabe, C., Medina, S., ... & Zhang, F. (2020). Disease-associated astrocytes in Alzheimer’s disease and aging. Nature Neuroscience, 23(6), 701-706.
[13] Zhang, S., Kim, B., Zhu, X., Gu, X., Wang, Y., Zhou, S., ... & Zhao, G. (2022). Glutamate transporter dysfunction associated with damage to oligodendrocytes in multiple sclerosis. Nature Neuroscience, 25(2), 258–269.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
